{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:42:52Z","timestamp":1782225772735,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":4279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1053\/joca.2002.0526","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:56:27Z","timestamp":1032429387000},"page":"471-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model"],"prefix":"10.1053","volume":"10","author":[{"given":"J.-H.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-Y.","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-I.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-K.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-J.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-B.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/joca.2002.0526_RF1","series-title":"Joint Cartilage Degradation","author":"Woessner","year":"1993"},{"key":"10.1053\/joca.2002.0526_RF2","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1074\/jbc.274.10.6594","article-title":"Generation and Chracterization of aggrecanase","volume":"274","author":"Arner","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1053\/joca.2002.0526_RF3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/ard.50.6.395","article-title":"Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis","volume":"50","author":"Kirkham","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/joca.2002.0526_RF4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/03009749009096939","article-title":"The role of cytokines in the development of osteoathritis","volume":"81","author":"Loyau","year":"1990","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1053\/joca.2002.0526_RF5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0049-0172(96)80036-9","article-title":"Cytokines in osteoarthritis: Mediators on markers of joint destruction","volume":"25","author":"Westacott","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/joca.2002.0526_RF6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0889-857X(21)00165-4","article-title":"Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?","volume":"19","author":"Brandt","year":"1993","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/joca.2002.0526_RF7","first-page":"8","article-title":"Pathogenesis of osteoarthritis-approaches to specific therapy","volume":"28","author":"Niethard","year":"1999","journal-title":"Am J Orthop"},{"key":"10.1053\/joca.2002.0526_RF8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-0172(99)80021-3","article-title":"The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment","volume":"28","author":"Ghosh","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/joca.2002.0526_RF9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-857X(05)70116-2","article-title":"Glucosamine in the treatment of osteoarthritis","volume":"26","author":"Delafuente","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/joca.2002.0526_RF10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0022-3565(24)34938-9","article-title":"Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage\/chondrocyte cultures by the natural product, hymenialdisine","volume":"290","author":"Badger","year":"1999","journal-title":"J Pharm Exp Ther"},{"key":"10.1053\/joca.2002.0526_RF11","first-page":"385","article-title":"Preparation of antiinflammatory herbal drug, SKI306X","volume":"39","author":"Park","year":"1995","journal-title":"Yakhak Hoeji"},{"key":"10.1053\/joca.2002.0526_RF12","first-page":"19","article-title":"Subacute toxicity of SKI306X, an antiinflammatory herbal extract, in rats","volume":"1","author":"Kim","year":"1996","journal-title":"J Applied Pharmacol"},{"key":"10.1053\/joca.2002.0526_RF13","unstructured":"Jung, YB, Roh, KJ, Jung, JA, Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled study, Am J Chinese Med"},{"key":"10.1053\/joca.2002.0526_RF14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0304-4165(78)90308-2","article-title":"Degradation of proteoglycan in articular cartilage","volume":"543","author":"Sandy","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/joca.2002.0526_RF15","first-page":"654","article-title":"Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis","volume":"26","author":"Yamada","year":"1999","journal-title":"J Rheum"},{"key":"10.1053\/joca.2002.0526_RF16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/03008208808992791","article-title":"The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans","volume":"17","author":"Templeton","year":"1988","journal-title":"Connect Tissue Res"},{"key":"10.1053\/joca.2002.0526_RF17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1063-4584(05)80319-X","article-title":"Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis","volume":"4","author":"Kikuchi","year":"1996","journal-title":"Osteoarthritis Cart"},{"key":"10.1053\/joca.2002.0526_RF18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/joca.1998.0110","article-title":"Intra-articular injection of collagenase induces experimental osteoarthritis in mature rabbits","volume":"6","author":"Kikuchi","year":"1998","journal-title":"Osteoarthritis Cart"},{"key":"10.1053\/joca.2002.0526_RF19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/joca.1998.0217","article-title":"The role of COX-2 produced by cartilage in arthritis","volume":"7","author":"Abramson","year":"1999","journal-title":"Osteoarthritis Cart"},{"key":"10.1053\/joca.2002.0526_RF20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1248\/bpb.22.727","article-title":"Dexamethasone inhibits collagen degradation induced by the combination of interleukin-1 and plasminogen in cartilage explant culture","volume":"22","author":"Saito","year":"1999","journal-title":"Biol Pharm Bull"},{"key":"10.1053\/joca.2002.0526_RF21","first-page":"266","article-title":"The therapeutic effects of NSAID and corticosteroids in osteoarthritis: to be or not to be","volume":"16","author":"Pelletier","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1053\/joca.2002.0526_RF22","series-title":"Effects of Drugs on Osteoarthrosis","first-page":"90","article-title":"Preclinical investigations of drug effects in models of osteoarthrosis","author":"Maier","year":"1984"},{"key":"10.1053\/joca.2002.0526_RF23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2165\/00003495-198020010-00002","article-title":"Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin","volume":"20","author":"Brogden","year":"1980","journal-title":"Drugs"},{"key":"10.1053\/joca.2002.0526_RF24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-199958030-00016","article-title":"Rofecoxib","volume":"58","author":"Scott","year":"1999","journal-title":"Drugs"},{"key":"10.1053\/joca.2002.0526_RF25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.2042-7158.1989.tb06514.x","article-title":"Studies on interleukin-1\u03b2 induced glycosaminoglycan release from rat femoral head cartilage in-vitro","volume":"41","author":"Clay","year":"1989","journal-title":"J Pharm Pharmacol"},{"key":"10.1053\/joca.2002.0526_RF26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/ard.52.4.292","article-title":"Effect of tenidap on cartilage integrity in vitro","volume":"52","author":"Dingle","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/joca.2002.0526_RF27","first-page":"1130","article-title":"Nonsteroidal antiinflammatory drugs: Effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro","volume":"22","author":"Smith","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/joca.2002.0526_RF28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-5793(95)00085-N","article-title":"Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes","volume":"360","author":"Ito","year":"1995","journal-title":"FEBS Letters"},{"key":"10.1053\/joca.2002.0526_RF29","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198905183202006","article-title":"The biology of osteoarthritis","volume":"320","author":"Hamerman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/joca.2002.0526_RF30","doi-asserted-by":"crossref","first-page":"20069","DOI":"10.1074\/jbc.M907604199","article-title":"Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis","volume":"275","author":"Tiku","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/joca.2002.0526_RF31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/cbir.1999.0424","article-title":"Reactive oxygen species induce apoptosis of synoviocytes in vitro. Alpha-tocopherol provides no protection","volume":"23","author":"Calleron","year":"1999","journal-title":"Cell Biol Int"},{"key":"10.1053\/joca.2002.0526_RF32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1006\/bbrc.1998.9561","article-title":"Expression and activity of articular cartilage hyanulronidases","volume":"241","author":"Flannery","year":"1998","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1053\/joca.2002.0526_RF33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0945-053X(00)00078-0","article-title":"Mechanisms involved in cartilage proteoglycan catabolism","volume":"19","author":"Caterson","year":"2000","journal-title":"Matrix Biol"},{"key":"10.1053\/joca.2002.0526_RF34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(96)00015-0","article-title":"Metalloproteinase inhibitors and the prevention of connective tissue breakdown","volume":"70","author":"Cawston","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1053\/joca.2002.0526_RF35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0945-053X(97)90025-1","article-title":"Relating matrix metalloproteinase structure to function: why the hemopexin domain","volume":"15","author":"Murphy","year":"1997","journal-title":"Matrix Biol"},{"key":"10.1053\/joca.2002.0526_RF36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj3440061","article-title":"Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro","volume":"344","author":"Little","year":"1999","journal-title":"Biochem J"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458402905261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458402905261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:02:52Z","timestamp":1761015772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458402905261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S1063458402905261"],"URL":"https:\/\/doi.org\/10.1053\/joca.2002.0526","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/joca.2002.0526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}